Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function
- PMID: 22211188
- PMCID: PMC3042794
- DOI: 10.3945/an.110.000117
Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function
Abstract
Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian, Melissa officinalis, sage), and phenolic compounds (curcumin, resveratrol, epigallocatechin-3-gallate, Hypericum perforatum, soy isoflavones). They are discussed in terms of how an increased understanding of the relationship between their ecological roles and CNS effects might further the field of natural, phytochemical drug discovery.
Conflict of interest statement
Author disclosures: D. Kennedy and E. Wightman, no conflicts of interest.
Figures
References
-
- Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461–77 - PubMed
-
- Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007;14:289–300 - PubMed
-
- National Institute of Clinical Excellence NICE technology appraisal guidance. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease (amended). London: National Institute of Clinical Excellence; 2009
-
- Pimentel D, Andow DA. Pest-management and pesticide impacts. Insect Sci Appl. 1984;5:141–9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
